| Response to:'The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region’by Rinaudo-Gaujous et al KA Van Schie, MH Hart, ER de Groot, S Kruithof, LA Aarden, GJ Wolbink, ... Annals of the Rheumatic Diseases 74 (8), e41-e41, 2015 | 150* | 2015 |
| The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region KA van Schie, MH Hart, ER de Groot, S Kruithof, LA Aarden, GJ Wolbink, ... Annals of the rheumatic diseases 74 (1), 311-314, 2015 | 146 | 2015 |
| Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology M Volkov, KA van Schie, D van der Woude Immunological Reviews 294 (1), 148-163, 2020 | 138 | 2020 |
| Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region FS Van De Bovenkamp, NIL Derksen, P Ooijevaar-de Heer, KA Van Schie, ... Proceedings of the National Academy of Sciences 115 (8), 1901-1906, 2018 | 115 | 2018 |
| Cross-reactive and pre-existing antibodies to therapeutic antibodies—effects on treatment and immunogenicity KA van Schie, GJ Wolbink, T Rispens MAbs 7 (4), 662-671, 2015 | 99 | 2015 |
| Functional analysis of the anti-adalimumab response using patient-derived monoclonal antibodies PA van Schouwenburg, S Kruithof, C Votsmeier, K van Schie, MH Hart, ... Journal of Biological Chemistry 289 (50), 34482-34488, 2014 | 64 | 2014 |
| Therapeutic TNF inhibitors can differentially stabilize trimeric TNF by inhibiting monomer exchange KA van Schie, P Ooijevaar-de Heer, L Dijk, S Kruithof, G Wolbink, ... Scientific reports 6 (1), 32747, 2016 | 59 | 2016 |
| On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis T Kissel, KA van Schie, L Hafkenscheid, A Lundquist, H Kokkonen, ... Annals of the rheumatic diseases 78 (12), 1616-1620, 2019 | 51 | 2019 |
| TNF-anti-TNF immune complexes inhibit IL-12/IL-23 secretion by inflammatory macrophages via an fc-dependent mechanism FM Bloemendaal, PJ Koelink, KA van Schie, T Rispens, CP Peters, ... Journal of Crohn's and Colitis 12 (9), 1122-1130, 2018 | 45 | 2018 |
| Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation T Kissel, C Ge, L Hafkenscheid, JC Kwekkeboom, LM Slot, M Cavallari, ... Science advances 8 (6), eabm1759, 2022 | 37 | 2022 |
| Neutralizing capacity of monoclonal and polyclonal anti-natalizumab antibodies: The immune response to antibody therapeutics preferentially targets the antigen-binding site KA van Schie, S Kruithof, PA van Schouwenburg, A Vennegoor, ... Journal of Allergy and Clinical Immunology 139 (3), 1035-1037. e6, 2017 | 28 | 2017 |
| A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer MK Magnusson, R Kraaij, RM Leadley, CMA De Ridder, ... Human gene therapy 23 (1), 70-82, 2012 | 28 | 2012 |
| Restricted immune activation and internalisation of anti-idiotype complexes between drug and antidrug antibodies KA van Schie, S Kruithof, P Ooijevaar-de Heer, NIL Derksen, ... Annals of the rheumatic diseases 77 (10), 1471-1479, 2018 | 27 | 2018 |
| Comprehensive overview of autoantibody isotype and subclass distribution M Volkov, M Coppola, R Huizinga, F Eftimov, TWJ Huizinga, ... Journal of Allergy and Clinical Immunology 150 (5), 999-1010, 2022 | 21 | 2022 |
| Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies KA van Schie, P Ooijevaar-De Heer, S Kruithof, C Plasencia, T Jurado, ... Annals of the rheumatic diseases 76 (7), 1285-1288, 2017 | 17 | 2017 |
| IgG Fab Glycans Hinder FcRn-Mediated Placental Transport M Volkov, M Brinkhaus, KA van Schie, A Bondt, T Kissel, EJ van der Kooi, ... The Journal of Immunology 210 (2), 158-167, 2023 | 7 | 2023 |
| Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modifications M Volkov, ASB Kampstra, KA van Schie, A Kawakami, M Tamai, ... Arthritis Research & Therapy 23 (1), 1-10, 2021 | 7 | 2021 |
| Multifunctional, multivalent PIC polymer scaffolds for targeting antigen-specific, autoreactive B cells H Kristyanto, MD Holborough-Kerkvliet, L Lelieveldt, Y Bartels, ... ACS Biomaterials Science & Engineering 8 (4), 1486-1493, 2022 | 6 | 2022 |
| AB0020 ACPA ILLUSTRATING THE IMPACT OF IGG FAB-GLYCOSYLATION ON TRANSPLACENTAL TRANSFER OF ANTIBODIES AND THEIR BINDING TO THE NEONATAL FC-RECEPTOR (FCRN) M Volkov, K Van Schie, A Bondt, T Kissel, M Brinkhaus, A Bentlage, ... Annals of the Rheumatic Diseases 80 (Suppl 1), 1044-1044, 2021 | 2 | 2021 |
| Type 17 specific immune pathways are active in early spondyloarthritis C Hughes, S Ryan, K Steel, M van den Beukel, L Trouw, K van Schie, ... | 1 | 2022 |
